» Articles » PMID: 19715898

Bone Marrow Transplantation Induces Normoglycemia in a Type 2 Diabetes Mellitus Murine Model

Overview
Journal Transplant Proc
Specialty General Surgery
Date 2009 Sep 1
PMID 19715898
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the cellular mechanisms involved in the regression of diabetic nephropathy, bone marrow-derived cells must be identified. The aim of this study was to obtain a diabetic chimeric model with bone marrow cells expressing enhanced green fluorecence protein (EGFP), without modifying the course of diabetic nephropathy.

Materials And Methods: Bone marrow transplantation (BMT) was performed in an obese type 2 diabetic murine model (db/db) owing to a mutation in the leptin receptor gene. Whole bone marrow from female donor C57BL/6 EGFP+ mice was transplanted into 8-week-old C57BL/6 mice and into 8- and 24-week-old female C57BLKS (db/db) EGFP- mice. Recipient mice received total body irradiation (TBI) followed by bone marrow (BM) cell infusion. We tested various irradiation doses (Gy) and numbers of BM cells.

Results: When a low TBI dose and a small number of BM cells were administered, only syngeneic C57BL/6 mice became chimeric, whereas allogeneic db/db mice showed rejection. When Gy dose and BM cells were increased, db/db mice became chimeric. However, 8-week-old db/db mice lost the obese phenotype and became normoglycemic, probably due to peripheral BM cell infiltration. Conversely, 24-week-old db/db mice remained obese showing similar blood glucose values, body weights, albuminuria, and glomerular lesions at nontransplanted db/db mice.

Conclusions: Recipient age greatly influenced the peripheral repopulation after BMT in db/db mice. Only the adult chimeric db/db mice seemed to be a good model to study the cellular mechanisms involved in the regression of diabetic nephropathy.

Citing Articles

Ly6C Inflammatory Monocyte Differentiation Partially Mediates Hyperhomocysteinemia-Induced Vascular Dysfunction in Type 2 Diabetic db/db Mice.

Fang P, Li X, Shan H, Saredy J, Cueto R, Xia J Arterioscler Thromb Vasc Biol. 2019; 39(10):2097-2119.

PMID: 31366217 PMC: 6761027. DOI: 10.1161/ATVBAHA.119.313138.


Exploring macrophage cell therapy on Diabetic Kidney Disease.

Guiteras R, Sola A, Flaquer M, Manonelles A, Hotter G, Cruzado J J Cell Mol Med. 2018; 23(2):841-851.

PMID: 30407737 PMC: 6349346. DOI: 10.1111/jcmm.13983.


Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.

Turcotte L, Yingst A, Verneris M Biol Blood Marrow Transplant. 2016; 22(7):1159-1166.

PMID: 27013015 PMC: 4905800. DOI: 10.1016/j.bbmt.2016.03.016.


Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.

Rojas M, Zhang W, Xu Z, Lemtalsi T, Chandler P, Toque H PLoS One. 2013; 8(12):e84357.

PMID: 24358357 PMC: 3866146. DOI: 10.1371/journal.pone.0084357.


Stem cell transplantation increases antioxidant effects in diabetic mice.

Li M, Vanella L, Zhang Y, Shi M, Takaki T, Shapiro J Int J Biol Sci. 2012; 8(10):1335-44.

PMID: 23139632 PMC: 3492792. DOI: 10.7150/ijbs.4654.